Abstract
Many factors are associated with medication non-adherence in Parkinson's disease (PD), including complex treatment regimens, mood disorders and impaired cognition. However, interventions to improve adherence which acknowledge such factors are lacking. A phase II randomised controlled trial was conducted investigating whether Adherence Therapy (AT) improves medication adherence and quality of life (QoL) compared with routine care (RC) in PD.
Original language | English |
---|---|
Pages (from-to) | 963-971 |
Number of pages | 9 |
Journal | International Journal of Clinical Practice |
Volume | 68 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2014 |